Advertisement
Screener

IRIDEX CORP (IRIX) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock

1.2 / 5 stars · 28/120 Roast Me

IRIDEX CORP Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock

IRIDEX CORP (IRIX) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 448.00 thousand shares for the 12-month period ending 2013-12-28, per its 10-K filed 2016-03-31.

Discontinued › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2016-03-31

  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2013-09-28 was 0.00 shares.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2013-06-29 was 792.00K shares, a 20.80% decline year-over-year.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2013-03-30 was 1.00M shares.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2012-09-29 was 0.00 shares, a 100.00% decline year-over-year.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2013 was 448.00K shares.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2012 was 0.00 shares, a 100.00% decline from fiscal 2011.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2011 was 1.00M shares, a 0.00% change from fiscal 2011.
  • IRIDEX CORP incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2011 was 1.00M shares.
Period endIncremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 monthIncremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month
2013-12-28448.00K shares
10-K · filed 2016-03-31
2013-09-280.00 shares
10-Q · filed 2013-11-04
597.00K shares
10-Q · filed 2014-11-03
2013-06-29792.00K shares
10-Q · filed 2014-08-04
895.00K shares
10-Q · filed 2014-08-04
2013-03-301.00M shares
10-Q · filed 2014-05-05
2012-12-290.00 shares
10-K · filed 2013-03-28
2012-09-290.00 shares
10-Q · filed 2013-11-04
0.00 shares
10-Q · filed 2013-11-04
2012-06-301.00M shares
10-Q · filed 2013-08-05
1.00M shares
10-Q · filed 2013-08-05
2012-03-310.00 shares
10-Q · filed 2013-05-06
2011-12-311.00M shares
10-K · filed 2014-03-27
2011-10-011.00M shares
10-Q · filed 2012-11-05
1.00M shares
10-Q · filed 2012-11-05
2011-07-021.00M shares
10-Q · filed 2012-08-07
1.00M shares
10-Q · filed 2012-08-07
2011-01-011.00M shares
10-K · filed 2013-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B